1 / 11

Radiodermatitis market analysis

Radiodermatitis Market, By Product Type (Topical Agents (Corticosteroids, Hydrophilic Creams, Others), Oral Medication (Corticosteroids, Other (Analgesic & Anti-Inflammatory)), Dressings (Hydrogel, Hydrocolloid, No Sting Barrier Film, Honey Impregnated Dressing, Silicone coated Dressing, Others)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

sriramnanda
Download Presentation

Radiodermatitis market analysis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. https://www.coherentmarketinsights.com/ COVID-19 IMPACT TRACKER Coherent Market Insights Market Research and Business Consulting Services

  2. Radiodermatitis Market, By Product Type (Topical Agents (Corticosteroids, Hydrophilic Creams, Others), Oral Medication (Corticosteroids, Other (Analgesic & Anti-Inflammatory)), Dressings (Hydrogel, Hydrocolloid, No Sting Barrier Film, Honey Impregnated Dressing, Silicone coated Dressing, Others)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027 RADIODERMATITIS MARKET ANALYSIS

  3. Radiodermatitis, also known as x-ray dermatitis, radiation dermatitis, radiation-induced skin reactions, or radiation injury, is a side effect of external beam ionizing radiation. Radiotherapy, used in the treatment of cancer or other diseases, is a major cause of radiodermatitis. The condition can also be a result of nuclear attacks and disasters. The global radiodermatitis market is estimated to account for US$ 360.5 Mn in terms of value and is expected to reach US$ 472.8 Mn by the end of 2027. Global Radiodermatitis Market: Drivers        Increasing prevalence of cancer is expected to propel growth of the global radiodermatitis market over the forecast period. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S. Moreover, R&D of new therapies for the treatment of radiodermatitis is also expected to aid in growth of the market. For instance, in December 2019, Kannalife, Inc. filed a new U.S. Patent for its proprietary and novel CBD-like molecules for the treatment of radiodermatitis and other skin disorders. Topical agents held dominant position in the global radiodermatitis market in 2019, accounting for 70.5% share in terms of value, followed by dressing and oral medication, respectively

  4.  Global Radiodermatitis Market Value (US$ Mn), and Y-o-Y Growth (%), 2019-2027

  5. Global Radiodermatitis Market: Restraints Introduction of better radiation therapy equipment is expected to hinder growth of the global radiodermatitis market. The severity and likeliness to develop radiodermatitis can be either patient-related or treatment-related. The treatment-related factors include the type and quality of radiation beam and the location and size of the treatment field. Modern radiotherapy techniques, which include intensity-modulated radiation therapy (IMRT) and proton therapy, can diminish the risk for radiodermatitis by more accurately targeting tumor. Such scenario is expected to hinder growth of the market. Moreover, high cost dressings such as honey-impregnated dressings and silicone dressings is also expected to limit growth of the market. Global Radiodermatitis Market: Opportunities R&D in radiodermatitis is expected to offer lucrative growth opportunities for players in the global radiodermatitis market. For instance, Jay Pharma is expected to begin a pilot study centered around radiodermatitis in the second half of 2020. Moreover, investing in creating awareness regarding radiation-induced skin damage among caregivers and patients in regions with average standard care practices such as Asia Pacific, Latin America, and Middle East & Africa is also expected to aid in growth of the market. The global radiodermatitis market was valued at US$ 346.9 Mn in 2019 and is forecast to reach a value of US$ 472.8 Mn by 2027 at a CAGR of 3.9% between 2020 and 2027.

  6. Global Radiodermatitis Market Share (%), by Value, by Product Type, 2019

  7. Market Trends/Key Takeaways The prescription of topical products is high for the treatment of radiodermatitis. Despite insufficient evidence to support a particular product’s use, topical steroids and emollients are the most prescribed agents worldwide for the treatment of radiodermatitis. Aloe vera gel is used as an alternative herbal remedy. Gels can be useful in seborrhoeic areas, whereas creams can be used in areas outside skin folds and seborrhoeic areas. Over-the-counter (OTC) products are more preferred than prescription products in the treatment of radiodermatitis. This can be attributed to word of mouth recommendations, easy availability of OTC products online as well as from local pharmacies. Hydrophilic creams sooth itching and redness and are available OTC. Value Chain Analysis The Value Chain for radiation dermatitis products begins from procurement of raw material, which would include API for oral medicine and silicone/hydrogel for silicone and hydrogel dressings. The material passes the stages of R&D, manufacturing, supply chain and finally is delivered to the end-users in clinics, hospitals or via retail stores (brick & mortar as well as online stores). Global Radiodermatitis Market: Competitive Landscape Major players operating in the global radiodermatitis market include, Acelity, Inc. (3M), BMG Pharma S.r.l., ConvaTec Group PLC, DermaSciences Inc. (Integra LifeSciences Holdings Corporation), Intermed Pharmaceuticals, Molnlycke Health Care, Smith & Nephew Plc, Stratpharma AG, Kannalife, Inc., and Jay Pharma Global Radiodermatitis Market: Key Developments         Major players in the market are focused on adopting M&A strategies to expand their product portfolio. For instance, in October 2019, 3M acquired Acelity, Inc. and its KCI subsidiaries. Similarly, in September 2019, Integra LifeSciences Holdings Corporation acquired Rebound Therapeutics, a developer of single-use medical devices that enable minimally invasive access in neurosurgery.

  8. Request Sample Report • Download PDF Brochure • Request Customisation • Talk to analyst • Reference-https://www.coherentmarketinsights.com/market-insight/automated-cpr-devices-market-3865

  9. AboutUS Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. What we provide: • Customized Market Research Services • Industry Analysis Services • Business Consulting Services • Market Intelligence Services • Long term Engagement Model • Country Specific Analysis

  10. Coherent Market Insights Pvt.Ltd. Address: 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Phone: +1-206-701-6702 Email: sales@coherentmarketinsights.com Contact Us

  11. THANKYOU • Kindly follow CMI Social Media Profiles for the latest company updates • FACEBOOK • LinkedIn • Twitter • https://www.coherentmarketinsights.com/

More Related